Xing Chang

机构：Westlake University, Guang’anmen Hospital, Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine, Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences · ORCID：0000-0002-3788-9881

发表论文 83 篇 · 总被引 3578 次 · h-index 31

代表论文

• Microtubules and cardiovascular diseases: insights into pathology and therapeutic strategies (2024 · The International Journal of Biochemistry & Cell Biology · 被引 98)
• Ginsenoside Rb1 attenuates coronary microvascular inflammatory injury via NDUFS4-SIRT5-DUSP1-mediated mitochondrial quality control in a murine ischemia-reperfusion model (2025 · Journal of Ginseng Research · 被引 82)
• The effect of unhealthy lifestyle on the pathogenesis of sick sinus syndrome: A life-guiding review (2024 · Medicine · 被引 64)
• Dialogue between mitochondria and endoplasmic reticulum-potential therapeutic targets for age-related cardiovascular diseases (2024 · Frontiers in Pharmacology · 被引 19)
• Zishen Huoxue decoction (ZSHX) alleviates ischemic myocardial injury (MI) via Sirt5-β-tubulin mediated synergistic mechanism of “mitophagy-unfolded protein response” and mitophagy (2025 · Chinese Journal of Natural Medicines · 被引 18)
• Phosphoglycerate mutase 5 exacerbates alcoholic cardiomyopathy in male mice by inducing prohibitin‐2 dephosphorylation and impairing mitochondrial quality control (2024 · Clinical and Translational Medicine · 被引 16)